Le Lézard
Classified in: Health, Business, Covid-19 virus
Subject: SVY

As Return-to-Work Becomes Reality, New Data Shows Companies Lack Plans to Manage Infectious Disease Outbreaks

AUSTIN, Texas, April 14, 2021 /PRNewswire-PRWeb/ -- ReturnSafe, the comprehensive software solution for infectious disease management (IDM) helping businesses reopen and stay open, today released findings from its new study on return-to-work strategies and the future of infectious disease in the workplace. Findings paint an uncertain future as companies struggle to develop strategies to bring employees back to work safely. More than half of survey respondents do not currently have policies on vaccination requirements (52 percent) or managing future infectious diseases outbreaks (49 percent).

"Returning to a sense of normalcy is palpable. After a year of navigating remote work that negatively impacted business outcomes for many, it's understandable that employers want to get people back into physical workspaces as soon as possible," said Tarun Nimmagadda, CEO and Co-Founder of ReturnSafe. "But the pandemic isn't over, and future outbreaks remain a threat to employee health and wellbeing. We need to ensure that every workplace has a long-term solution to address issues related to COVID-19 and beyond. It's clear from our survey findings that employees are extremely concerned about how employers plan to manage vaccinations, social distancing, and infectious diseases down the line."

Key findings from the report show:

"Our findings show that nearly half of employers don't have a vaccination policy in place, meaning they must deal with the complexities of mixed-immunity environments," said Jikku Venkat, Chief Technology Officer, Vice President of Product, and Co-Founder of ReturnSafe. "Companies need tools like daily health screeners, testing dashboards and case managers to not only prevent COVID-related healthcare costs from spiraling out of control, but to ease employees' concerns and instill confidence that their health and safety is a top priority."

To view the full survey report or learn more about ReturnSafe, visit https://returnsafe.com/.


Survey Methodology:
A survey of 122 companies was conducted from March 17-31, 2021 to better understand how employers are planning return-to-work strategies and thinking about the future of infectious disease in the workplace. Respondents were asked 21 questions that pertain to the future of work and managing mixed-immunity work environments.

The Survey was commissioned and executed by ReturnSafe.

About ReturnSafe
ReturnSafe is a holistic software solution for infectious disease management (IDM) that is helping businesses, universities, healthcare facilities, sports teams and major venues businesses reopen and stay open. Its end-to-end platform provides daily health screening, exposure notification, and contact tracing and case management for COVID-19 and other contagious diseases. ReturnSafe is based in Austin, TX and backed by Fifty Years, Necessary Ventures and Active Capital. To help keep everyone in your organization safe with human-driven, technology-supported solutions, visit http://www.returnsafe.com.

Media Contact

Tess Pawlisch, The Key PR, 6083339788, returnsafe@thekeypr.com


SOURCE ReturnSafe

These press releases may also interest you

at 07:10
Parallel (the "Company"), one of the largest privately-held multi-state cannabis operators in the United States (U.S.), today announced the completion of a sale-leaseback transaction (the "Transaction"), in which Parallel sold its Pittsburgh,...

at 07:07
After announcing its official launch into Europe last week, GoGlobal today announced members of its European leadership team. GoGlobal, a leading Professional Employment Organization (PEO) providing Employer of Record (EoR) services, helps companies...

at 07:07
Hamilton Pacific Chamberlain (HPC), a service disabled veteran owned small business (SDVOSB) headquartered in Waldorf, MD, has announced the acquisition of multiple million-dollar federal contracts spanning various VA Medical Centers in Maryland and...

at 07:05
Forma Therapeutics Holdings, Inc. , a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today reported financial results for the first quarter ended March 31, 2021. The company also highlighted recent progress...

at 07:05
FLYHT Aerospace Solutions Ltd.  (the "Company" or "FLYHT") would like to correct the number of shares previously announced on May 10, 2021 from an aggregate 248,355 common shares to an aggregate 434,555, subject to regulatory approval, to employees,...

at 07:02
Vireo Health International, Inc. ("Vireo" or the "Company") , the leading physician-led, science-focused multi-state cannabis company, today reported financial results for its first quarter ended March 31, 2021. All currency figures referenced in...

News published on 14 april 2021 at 11:00 and distributed by: